• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Qualitative Analysis of Perspectives on Lung Transplant among People with Cystic Fibrosis.囊性纤维化患者肺移植观点的定性分析。
Ann Am Thorac Soc. 2024 Jul;21(7):1044-1052. doi: 10.1513/AnnalsATS.202307-625OC.
2
Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.父母及非正式照料者关于儿童常规疫苗接种沟通的观点与经历:定性证据综述
Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011787. doi: 10.1002/14651858.CD011787.pub2.
3
Personal narratives to support learning about lung transplant for people with cystic fibrosis.支持囊性纤维化患者了解肺移植的个人叙述。
Patient Educ Couns. 2025 Aug;137:108822. doi: 10.1016/j.pec.2025.108822. Epub 2025 May 5.
4
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
5
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对携带 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(有或没有增效剂)。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4.
6
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.
7
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.一项定性访谈研究,探讨英国化脓性汗腺炎患者对治疗的看法和经历。
Br J Dermatol. 2025 Jun 20;193(1):85-92. doi: 10.1093/bjd/ljaf046.

引用本文的文献

1
Lived experiences for individuals with cystic fibrosis who have undergone lung transplantation: a qualitative study.接受肺移植的囊性纤维化患者的生活经历:一项定性研究。
BMC Nurs. 2025 Feb 3;24(1):127. doi: 10.1186/s12912-025-02774-x.
2
A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor.囊性纤维化医生在 elexacaftor/tezacaftor/ivacaftor 时代对肺移植转诊的看法调查。
Pediatr Pulmonol. 2024 Dec;59(12):3641-3649. doi: 10.1002/ppul.27273. Epub 2024 Sep 18.

本文引用的文献

1
Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study.依列卡福妥/替扎卡福妥/依伐卡托在囊性纤维化患者中的真实世界安全性和有效性:一项基于长期注册研究的中期结果
J Cyst Fibros. 2023 Jul;22(4):730-737. doi: 10.1016/j.jcf.2023.03.002. Epub 2023 Mar 22.
2
EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS.依洛卡托/泰他卡托/维加卡托对囊性纤维化患者肺功能下降年率的影响。
J Cyst Fibros. 2023 May;22(3):402-406. doi: 10.1016/j.jcf.2022.12.009. Epub 2022 Dec 27.
3
Changing racial and ethnic differences for lung transplantation in cystic fibrosis.改变肺移植中种族和民族差异在囊性纤维化。
Pediatr Transplant. 2023 Feb;27(1):e14404. doi: 10.1111/petr.14404. Epub 2022 Oct 7.
4
Take on transplant: human-centered design of a patient education tool to facilitate informed discussions about lung transplant among people with cystic fibrosis.开展肺移植:以患者为中心设计的教育工具,促进囊性纤维化患者之间关于肺移植的知情讨论。
J Am Med Inform Assoc. 2022 Dec 13;30(1):26-37. doi: 10.1093/jamia/ocac176.
5
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.肺移植候选者中依伐卡托与泰它卡托与艾克卡托联合治疗囊性纤维化的持续有效性。
J Cyst Fibros. 2022 May;21(3):489-496. doi: 10.1016/j.jcf.2022.01.012. Epub 2022 Feb 2.
6
Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France.法国囊性纤维化患者的肺移植数量大幅下降。
Am J Respir Crit Care Med. 2022 Mar 1;205(5):584-586. doi: 10.1164/rccm.202109-2121LE.
7
Developing a Decision Aid to Facilitate Informed Decision Making About Invasive Mechanical Ventilation and Lung Transplantation Among Adults With Cystic Fibrosis: Usability Testing.开发一种决策辅助工具,以促进囊性纤维化成年患者在有创机械通气和肺移植方面做出明智的决策:可用性测试
JMIR Hum Factors. 2021 Apr 14;8(2):e21270. doi: 10.2196/21270.
8
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report - 2020; focus on deceased donor characteristics.国际心肺移植学会国际胸科器官移植登记处:第37份成人肺移植报告 - 2020;关注脑死亡供体特征
J Heart Lung Transplant. 2020 Oct;39(10):1016-1027. doi: 10.1016/j.healun.2020.07.009. Epub 2020 Jul 30.
9
Incorporating patient and caregiver feedback into lung transplant referral guidelines for individuals with cystic fibrosis-Preliminary findings from a novel paradigm.将患者和护理人员的反馈纳入囊性纤维化患者的肺移植转诊指南——一种新范式的初步发现。
Clin Transplant. 2020 Oct;34(10):e14038. doi: 10.1111/ctr.14038. Epub 2020 Aug 17.
10
Using qualitative methods to inform the design of a decision aid for people with advanced cystic fibrosis: The InformedChoices CF patient decision aid.采用定性方法为先进囊性纤维化患者的决策辅助工具设计提供信息:知情选择 CF 患者决策辅助工具。
Patient Educ Couns. 2019 Nov;102(11):1985-1990. doi: 10.1016/j.pec.2019.06.007. Epub 2019 Jun 22.

囊性纤维化患者肺移植观点的定性分析。

Qualitative Analysis of Perspectives on Lung Transplant among People with Cystic Fibrosis.

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine.

Division of Biobehavioral and Health Informatics, Department of Nursing.

出版信息

Ann Am Thorac Soc. 2024 Jul;21(7):1044-1052. doi: 10.1513/AnnalsATS.202307-625OC.

DOI:10.1513/AnnalsATS.202307-625OC
PMID:38259137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11284319/
Abstract

Lung transplant (LTx) is a potentially lifesaving treatment option for individuals with advanced cystic fibrosis (CF), but more people with CF (PwCF) and advanced lung disease die each year than undergo transplant in the United States. Little is known about these individuals' LTx information needs and factors influencing their decision-making process related to transplant. To examine PwCF's experiences with and preferences for provision of LTx information and to identify transplant information needs that CF clinicians are well positioned to address. We performed semistructured qualitative interviews in two separate cohorts: PwCF without LTx and PwCF with LTx between July 2019 and June 2020. Questions focused on awareness and knowledge about LTx, perspectives related to communication about transplant in the CF clinic, and experiences with LTx. Thematic analysis was used to organize the qualitative data. Exemplar quotes were chosen to llustrate domains that emerged pertaining to the research objectives. Fifty-five PwCF, including 35 without LTx and 20 with LTx, participated. One-third of PwCF without LTx had normal or near-normal lung function. Key common domains among PwCF with and without LTx were identified, including information needs, connections with LTx recipients, and conversations with CF clinicians. For PwCF with and without transplant, concrete information needs were identified: success or survival, social support, surgery, recovery/pain, and quality of life post-transplant. The importance of connecting with LTx recipients to hear their stories and experiences was emphasized by both PwCF with and without transplant. Important considerations for timing and content of discussions with CF clinicians were identified, including having information presented early (before LTx referral is needed) and in limited detail at first. PwCF without LTx wanted to understand how LTx was relevant to them, with a focus on the unique experience of CF. PwCF with LTx emphasized the need for a centralized resource for LTx information. The findings provide content areas for CF clinicians to focus on as they proactively initiate conversations about LTx and support the development of tools to aid in discussions about LTx for PwCF.

摘要

肺移植(LTx)是治疗晚期囊性纤维化(CF)患者的一种潜在救生治疗选择,但每年因肺部疾病在美国接受移植的 CF 患者(PwCF)和晚期肺病患者多于死亡。人们对这些患者的 LTx 信息需求以及影响他们与移植相关决策的因素知之甚少。为了研究 PwCF 获取和偏好 LTx 信息的体验,以及确定 CF 临床医生能够很好地解决的移植信息需求。我们在 2019 年 7 月至 2020 年 6 月期间进行了两次独立队列的半结构式定性访谈:未进行 LTx 的 PwCF 和进行 LTx 的 PwCF。问题集中在对 LTx 的认识和了解、CF 诊所中关于移植的沟通观点,以及 LTx 体验。使用主题分析来组织定性数据。选择示例报价来说明与研究目标相关的领域。共有 55 名 PwCF 参与了研究,其中 35 名没有 LTx,20 名有 LTx。三分之一的没有 LTx 的 PwCF 肺功能正常或接近正常。确定了具有和没有 LTx 的 PwCF 之间存在的共同关键领域,包括信息需求、与 LTx 受者的联系以及与 CF 临床医生的对话。对于有和没有移植的 PwCF,都确定了具体的信息需求:成功或存活、社会支持、手术、康复/疼痛和移植后的生活质量。与 LTx 受者联系以听取他们的故事和经验的重要性被有和没有移植的 PwCF 都强调。确定了与 CF 临床医生讨论的时间和内容的重要考虑因素,包括在需要进行 LTx 转诊之前及早(并首先以有限的细节)提供信息。没有 LTx 的 PwCF 希望了解 LTx 与他们的相关性,重点是 CF 的独特体验。有 LTx 的 PwCF 强调需要一个 LTx 信息的集中资源。研究结果为 CF 临床医生提供了重点关注的内容领域,因为他们积极主动地开展关于 LTx 的对话,并支持开发工具,以帮助 PwCF 讨论 LTx。